Effects of Benzothiazole Compounds on Ovarian Cancer Growth
Author Information
Author(s): TD Bradshaw, D-F Shil, RJ Schultz, KD Paull, L Kelland, A Wilson, C Garner, HH Fiebig, S Wrigley, MFG Stevens
Primary Institution: University of Nottingham
Hypothesis
Can 2-(4-aminophenyl)benzothiazole compounds inhibit the growth of human ovarian carcinoma cells?
Conclusion
The study found that certain benzothiazole compounds significantly inhibit the growth of specific ovarian cancer cell lines both in vitro and in vivo.
Supporting Evidence
- Benzothiazole compounds showed selective inhibition of ovarian cancer cell lines.
- Growth inhibition was observed in both in vitro and in vivo models.
- Biphasic dose-response relationships were noted in sensitive cell lines.
Takeaway
Some new medicines can help stop ovarian cancer cells from growing, but they work better on some types of these cells than others.
Methodology
The study involved testing various benzothiazole compounds on different ovarian cancer cell lines in both laboratory and animal models.
Limitations
The study primarily focused on specific cell lines and may not represent all ovarian cancer types.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website